Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES. RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000
Medication labelWhy this: Advisory · dailymed-prescription
Rivastigmine tartrate capsules are indicated for the treatment of mild-to-moderate dementia of the Alzheimer's type (AD). Rivastigmine tartrate capsules are indicated for the treatment of mild-to-moderate dementia associated with Parkinson’s disease (PD).
- generic_name
- rivastigmine tartrate
- product_names
- Rivastigmine Tartrate
- ndc
- 62332-063, 62332-064, 62332-065, 62332-066, 62332-063-30, 62332-063-60, 62332-063-71, 62332-063-91, 62332-063-10, 62332-064-30, 62332-064-60, 62332-064-71, 62332-064-91, 62332-064-10, 62332-065-30, 62332-065-60, 62332-065-71, 62332-065-91, 62332-065-10, 62332-066-30, 62332-066-60, 62332-066-71, 62332-066-91, 62332-066-10
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en